Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $821.94 million. The enterprise value is $532.95 million.
Important Dates
The next confirmed earnings date is Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 67.43 million shares outstanding. The number of shares has increased by 117.29% in one year.
| Shares Outstanding | 67.43M |
| Shares Change (YoY) | +117.29% |
| Shares Change (QoQ) | +34.62% |
| Owned by Insiders (%) | 5.03% |
| Owned by Institutions (%) | 55.67% |
| Float | 43.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.41 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 364.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.73, with a Debt / Equity ratio of 0.01.
| Current Ratio | 27.73 |
| Quick Ratio | 27.62 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -529.52 |
Financial Efficiency
Return on equity (ROE) is -23.20% and return on invested capital (ROIC) is -13.35%.
| Return on Equity (ROE) | -23.20% |
| Return on Assets (ROA) | -12.03% |
| Return on Capital (ROIC) | -13.35% |
| Revenue Per Employee | $12,303 |
| Profits Per Employee | -$495,958 |
| Employee Count | 119 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CATX has paid $7.85 million in taxes.
| Income Tax | 7.85M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +345.87% in the last 52 weeks. The beta is 1.47, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | +345.87% |
| 50-Day Moving Average | 13.38 |
| 200-Day Moving Average | 12.62 |
| Relative Strength Index (RSI) | 46.93 |
| Average Volume (20 Days) | 856,272 |
Short Selling Information
The latest short interest is 7.88 million, so 11.69% of the outstanding shares have been sold short.
| Short Interest | 7.88M |
| Short Previous Month | 7.14M |
| Short % of Shares Out | 11.69% |
| Short % of Float | 18.18% |
| Short Ratio (days to cover) | 6.40 |
Income Statement
In the last 12 months, CATX had revenue of $1.46 million and -$59.02 million in losses. Loss per share was -$1.37.
| Revenue | 1.46M |
| Gross Profit | 1.46M |
| Operating Income | -48.72M |
| Pretax Income | -50.57M |
| Net Income | -59.02M |
| EBITDA | -47.27M |
| EBIT | -48.72M |
| Loss Per Share | -$1.37 |
Full Income StatementBalance Sheet
The company has $292.87 million in cash and $3.88 million in debt, giving a net cash position of $288.99 million or $4.29 per share.
| Cash & Cash Equivalents | 292.87M |
| Total Debt | 3.88M |
| Net Cash | 288.99M |
| Net Cash Per Share | $4.29 |
| Equity (Book Value) | 341.00M |
| Book Value Per Share | 5.06 |
| Working Capital | 283.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.17 million and capital expenditures -$10.40 million, giving a free cash flow of -$24.58 million.
| Operating Cash Flow | -14.17M |
| Capital Expenditures | -10.40M |
| Free Cash Flow | -24.58M |
| FCF Per Share | -$0.36 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -3,327.60% |
| Pretax Margin | -3,026.84% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 7,659.54% |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -117.29% |
| Shareholder Yield | -117.29% |
| Earnings Yield | -7.18% |
| FCF Yield | -2.99% |
Analyst Forecast
The average price target for CATX is $21.63, which is 77.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.63 |
| Price Target Difference | 77.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 78.02% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
CATX has an Altman Z-Score of 4.94 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.94 |
| Piotroski F-Score | 3 |